Harry Nisen

6PUBLICATIONS
43CO-AUTHORS
Nutrigenomics and personalised nutritionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Health and ecological risk assessmentCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 28, 2025
Integrin Trafficking, Fibronectin Architecture, and Glomerular Injury upon Adiponectin Receptor 1 Depletion.

Sonja Lindfors, Constanze Schmotz, Dominik Lewandowski

|Jul 24, 2023
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma.

Moon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen

|Jun 22, 2022
Intraoperative complications in kidney tumor surgery: critical grading for the European Association of Urology intraoperative adverse incident classification.

Harry Nisen, Kaisa Erkkilä, Otto Ettala

|Jun 17, 2022
Active surveillance versus initial surgery in the long-term management of Bosniak IIF-IV cystic renal masses.

Lassi Luomala, Juhana Rautiola, Petrus Järvinen

|May 14, 2021
Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo.

Sonja Lindfors, Zydrune Polianskyte-Prause, Rim Bouslama

|Apr 01, 2021
Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?

Yasmin Abu-Ghanem, Thomas Powles, Umberto Capitanio

Pageof 1

Frequent Collaborators

4 joint publications

Tuomas Mirtti

2 joint publications

Sonja Lindfors

2 joint publications

Petrus Järvinen

2 joint publications

Sanna Lehtonen